Marianne Tawa

852 total citations
17 papers, 588 citations indexed

About

Marianne Tawa is a scholar working on Dermatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Marianne Tawa has authored 17 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Dermatology, 11 papers in Pathology and Forensic Medicine and 8 papers in Epidemiology. Recurrent topics in Marianne Tawa's work include Cutaneous lymphoproliferative disorders research (16 papers), Lymphoma Diagnosis and Treatment (10 papers) and T-cell and Retrovirus Studies (7 papers). Marianne Tawa is often cited by papers focused on Cutaneous lymphoproliferative disorders research (16 papers), Lymphoma Diagnosis and Treatment (10 papers) and T-cell and Retrovirus Studies (7 papers). Marianne Tawa collaborates with scholars based in United States, Netherlands and Austria. Marianne Tawa's co-authors include Thomas S. Kupper, David C. Fisher, Rachael A. Clark, Jessica E. Teague, Rei Watanabe, Christoph Schlapbach, Nicole R. LeBoeuf, Keri Chaney, Joi B. Carter and Andrew DoRosario and has published in prestigious journals such as Blood, Clinical Cancer Research and Science Translational Medicine.

In The Last Decade

Marianne Tawa

14 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marianne Tawa United States	7	356	348	215	171	127	17	588
Daniel Navi United States	8	263 0.7×	212 0.6×	131 0.6×	204 1.2×	151 1.2×	10	511
Steven Horwitz United States	6	362 1.0×	176 0.5×	252 1.2×	176 1.0×	141 1.1×	7	482
Chantal Lahet France	7	227 0.6×	129 0.4×	244 1.1×	110 0.6×	108 0.9×	7	352
B V Jegasothy United States	9	211 0.6×	154 0.4×	131 0.6×	114 0.7×	58 0.5×	12	362
Claus Gruss Germany	11	257 0.7×	120 0.3×	183 0.9×	72 0.4×	21 0.2×	18	426
Inger Christensen United States	10	510 1.4×	427 1.2×	260 1.2×	209 1.2×	186 1.5×	14	697
S Bisballe Denmark	8	204 0.6×	201 0.6×	109 0.5×	83 0.5×	135 1.1×	12	430
Luca Muscardin Italy	11	190 0.5×	51 0.1×	151 0.7×	143 0.8×	99 0.8×	41	406
Hatice Şanlı Türkiye	13	153 0.4×	91 0.3×	92 0.4×	74 0.4×	45 0.4×	31	303
Julie Lin United States	10	125 0.4×	141 0.4×	89 0.4×	44 0.3×	40 0.3×	19	316

Countries citing papers authored by Marianne Tawa

Since Specialization

Citations

This map shows the geographic impact of Marianne Tawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne Tawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne Tawa more than expected).

Fields of papers citing papers by Marianne Tawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne Tawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne Tawa. The network helps show where Marianne Tawa may publish in the future.

Co-authorship network of co-authors of Marianne Tawa

This figure shows the co-authorship network connecting the top 25 collaborators of Marianne Tawa. A scholar is included among the top collaborators of Marianne Tawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianne Tawa. Marianne Tawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tawa, Marianne, Elise A. Olsen, Julia Scarisbrick, et al.. (2025). Defining Core Concepts for Health‐Related Quality of Life for Patients With Mycosis Fungoides and Sézary Syndrome: A Systematic Literature Review. JEADV Clinical Practice. 4(4). 907–919.

Virgen, César A., Jeffrey A. Sparks, Anju Nohria, et al.. (2023). Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma. The Oncologist. 28(8). e694–e698. 3 indexed citations

Jfri, Abdulhadi, César A. Virgen, Marianne Tawa, et al.. (2023). Prevalence and implications of mogamulizumab-induced immune-related adverse events in mycosis fungoides/Sézary syndrome; a single-center experience. Journal of the American Academy of Dermatology. 89(5). 1044–1047. 3 indexed citations

Smith, Neal P., Jessica E. Teague, Pablo Vieyra-Garcia, et al.. (2022). IL-32 Supports the Survival of Malignant T Cells in Cutaneous T-cell Lymphoma. Journal of Investigative Dermatology. 142(8). 2285–2288.e2. 4 indexed citations

Tawa, Marianne, et al.. (2022). Inpatient Considerations in the Diagnosis and Management of the Cutaneous T-Cell Lymphoma Patient. Current Dermatology Reports. 11(4). 233–243.

Tawa, Marianne, et al.. (2019). Cutaneous T-Cell Lymphoma: Optimizing Care in Patients Receiving Anti-CCR4 Monoclonal Antibody Mogamulizumab. Clinical journal of oncology nursing. 23(4). E73–E80. 2 indexed citations

Masson, Adèle de, John T. O’Malley, Christopher P. Elco, et al.. (2018). High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides. Science Translational Medicine. 10(440). 81 indexed citations

Tawa, Marianne, et al.. (2017). Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature. BMC Cancer. 17(1). 20 indexed citations

Tawa, Marianne, et al.. (2016). Gelling Your Dermatology Nursing Practice. Journal of the Dermatology Nurses’ Association. 8(3). 180–192. 1 indexed citations

10.

Tawa, Marianne, et al.. (2015). Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel. Clinical journal of oncology nursing. 19(6). E131–E139. 10 indexed citations

11.

Tawa, Marianne. (2014). 7th World Congress on Itch. Journal of the Dermatology Nurses’ Association. 6(2). 82–83. 1 indexed citations

12.

Guenova, Emmanuella, Rei Watanabe, Jessica E. Teague, et al.. (2013). TH2 Cytokines from Malignant Cells Suppress TH1 Responses and Enforce a Global TH2 Bias in Leukemic Cutaneous T-cell Lymphoma. Clinical Cancer Research. 19(14). 3755–3763. 147 indexed citations

13.

Clark, Rachael A., Rei Watanabe, Jessica E. Teague, et al.. (2012). Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients. Science Translational Medicine. 4(117). 117ra7–117ra7. 279 indexed citations

14.

Booher, Susan, et al.. (2011). Cutaneous T-Cell Lymphoma. Journal of the Dermatology Nurses’ Association. 3(1). 18–32.

15.

Booher, Susan, et al.. (2011). Cutaneous T-Cell Lymphoma. Journal of the Dermatology Nurses’ Association. 3(2). 75–83. 3 indexed citations

16.

Richmond, Jillian M., Marina Tuzova, Ashley Parks, et al.. (2010). Interleukin-16 as a Marker of Sézary Syndrome Onset and Stage. Journal of Clinical Immunology. 31(1). 39–50. 21 indexed citations

17.

Fisher, David C., et al.. (2009). Low-Dose Alemtuzumab Is Uniquely Effective in Refractory Leukemic Cutaneous T Cell Lymphoma (L-CTCL).. Blood. 114(22). 3748–3748. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact